Cardioplexol
Cardioplexol is a medicine authorised by Swissmedic under authorisation number 68015. The authorisation holder is Medius AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 31 August 2023 and the authorisation is limited until 30 August 2028. ATC code B05XA16 places the medicine in the group Blood substitutes and perfusion solutions.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cardioplexol, Kardioplege Lösung | B | 31 August 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Set | B05XA16 | 02.99.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Cardioplexol authorised in Switzerland?
Yes. Cardioplexol is authorised by Swissmedic under authorisation number 68015, data as of 01 September 2026. The authorisation is limited until 30 August 2028.
Which dispensing category does Cardioplexol have?
Cardioplexol is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Cardioplexol?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.